Why the Bod (ASX:BDA) share price is soaring 11%

The Bod share price is soaring 12% today as the company announced strong sales in the second half of CY2020.

| More on:
ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bod Australia Ltd (ASX: BDA) share price is storming higher today as the company announced strong sales.

Shares in the medicinal cannabis company have soared on the news, gaining 10.47%. As a result the Bod share price is currently trading at 48 cents.

What’s driving the Bod share price?

This morning, Bod announced it had achieved strong cannabis sales for the second half of the calendar year 2020.

The company fulfilled 3941 prescriptions in the six-month period, up 91% on the previous half-year results of 2063. This means the cannabis producer has now filled more than 8000 prescriptions since July 2019.

The positive growth can be attributed to continued product uptake and strong brand recognition in Australia. In addition, the company’s nationwide study released last year has continued to educate Australians on the benefits of Bod’s products. This has generated more sales.

The company also noted that repeat prescribers accounted for 62% of the volume in the second half of 2020, indicating both patient and physician satisfaction.

What did management say?

Bod CEO Jo Patterson welcomed the news, saying:

It is very pleasing to see strong growth and continued support from patients and physicians for our MediCabilis product. MediCabilis is commonly prescribed for a range of chronic conditions, but most noticeably chronic pain and anxiety.

To treat these kinds of conditions, patients will always require a GMP pharmaceutical grade, standardised and consistent product. This is one of the key competitive advantages of MediCabilis and one of the reasons behind the company’s strong repeat prescription growth.

We expect strong demand for MediCabilis to continue across Australia and this growth will continue to add to our revenue profile. Board and management look forward to updating shareholders on sales progress in the coming months.

What now for the Bod share price

The Bod share price fell 18% in December although shareholders were rewarded with a 71% gain over the last 6 months. This has continued into the beginning of this year with today’s 11% intraday rise.

Thanks to the recent growth in MediCabilis sales and prescription volumes, Bod’s revenue profile has significantly increased. As a result, the company is expecting this growth to continue into the coming months both domestically and in the UK market.

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Investor sitting in front of multiple screens watching share prices
Share Market News

5 things to watch on the ASX 200 on Thursday

The ASX 200 is expected to have a better day on Thursday...

Read more »

Two hands being shaken symbolising a deal.
Mergers & Acquisitions

How many global mega deals involved ASX 200 shares in the first half of 2022?

Deal making among ASX 200 shares helped drive a 25.4% increase in M&A activity in Australia in the first half…

Read more »

Top 10 blank list on chalkboard
Share Market News

Here are the top 10 ASX shares today

Here are your top 10 biggest gainers in the ASX 200 on Wednesday.

Read more »

a man peers between two large piles of papers and files with a wide-eyed, wide-mouth look of dread at the amount of work he has to do.
Share Market News

Here are the 3 most heavily traded ASX 200 shares on Wednesday

We take a look at the most traded ASX 200 shares by volume today.

Read more »

workers stand over a large spool of copper pipe.
Share Market News

ASX copper shares in the red as copper price sinks to 19 month low

Copper prices fell in global markets overnight.

Read more »

Man with rocket wings which have flames coming out of them.
Share Market News

EML share price leaps 16% on Spanish government stimulus contract

EML shares are on fire on Wednesday...

Read more »

Share Market News

ASX 200 midday update: BHP and Fortescue sink, EML and ZIP jump

The ASX 200 is having a difficult day due to weakness in the mining sector...

Read more »

Business woman watching stocks and trends while thinking
Share Market News

5 things to watch on the ASX 200 on Wednesday

The ASX 200 looks set to have a tough day on Wednesday...

Read more »